MiR-1256 inhibits cell proliferation and cell cycle progression in papillary thyroid cancer by targeting 5-hydroxy tryptamine receptor 3A

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram et al. · CA A Cancer Journal for Clinicians · 2018 · 86.6K citations · Full text

Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors

Gabriella Pellegriti, Francesco Frasca, Concetto Regalbuto et al. · Journal of Cancer Epidemiology · 2013 · 1.3K citations · Full text

Thyroid cancer mortality and incidence: A global overview

Carlo La Vecchia, Matteo Malvezzi, Cristina Bosetti et al. · International Journal of Cancer · 2014 · 1K citations

Epidemiological Trend, Epidemiology, Cancer Epidemiology +15

Prognostic Factors for Persistent or Recurrent Disease of Papillary Thyroid Carcinoma with Neck Lymph Node Metastases and/or Tumor Extension beyond the Thyroid Capsule at Initial Diagnosis

Sophie Leboulleux, Carolé Rubino, Éric Baudin et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 587 citations · Full text

Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants

Xiaoguang Shi, Rengyun Liu, Fulvio Basolo et al. · The Journal of Clinical Endocrinology & Metabolism · 2015 · 201 citations · Full text